MAPT and Alzheimer disease: In fact, many proteins implicated in AD, such as tau, TMEM119, alpha4 and alpha7 neuronal nicotinic receptors, exhibit inconsistent changes between mRNA expression and protein level, which may be attributed to the post-transcriptional regulations [58–60].